{
  "id": "64688f766988e404",
  "title": "Opinion: New gonorrhea drug is not just a scientific breakthrough but a business one",
  "description": "Turning the tide on antibiotic resistance will require new ways of working, writes executive director of the Global Antibiotic Research &#038; Development Partnership.",
  "content": "Turning the tide on antibiotic resistance will require new ways of working, writes executive director of the Global Antibiotic Research &#038; Development Partnership.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/17/zoliflodacin-gonorrhea-gardp-innoviva-antibiotic-resistance/?utm_campaign=rss",
  "published_at": "2025-12-17T09:30:00+00:00",
  "fetched_at": "2025-12-18T00:22:47.263985+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "antibiotic"
  ],
  "location": null,
  "raw_data": {
    "title": "Opinion: New gonorrhea drug is not just a scientific breakthrough but a business one",
    "description": "Turning the tide on antibiotic resistance will require new ways of working, writes executive director of the Global Antibiotic Research &#038; Development Partnership.",
    "url": "https://www.statnews.com/2025/12/17/zoliflodacin-gonorrhea-gardp-innoviva-antibiotic-resistance/?utm_campaign=rss",
    "published": "2025-12-17T09:30:00+00:00",
    "source": "STAT"
  }
}